BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Affinity Technology Incorporated

Below is an extended Affinity Technology Incorporated news listing. Click here to return to the Affinity Technology Incorporated main Biocorporate entry.

BioNews Results for Affinity Technology Incorporated:

Polyplus-transfection announces the development of 'ZNA(TM)', a new class of modified oligonucleotides
BioPortfolio:  Sep 15 2008 2:51PM Matching: affinity technology
Examine the World Proteomics Market
Macro World Investor:  Sep 10 2008 4:09PM Matching: affinity technology
BAC Secures 1.5 M Series B R&D Financing for Affinity Products
BioPortfolio:  Sep 9 2008 11:35AM Matching: affinity technology
Identification of highly expressed, soluble proteins using an improved, high-throughput pooled ORF expression
Bio Techniques:  Sep 7 2008 11:59AM Matching: affinity technology

«Affinity Technology Incorporated

This page contained an extended Affinity Technology Incorporated news listing. Click here to return to the Affinity Technology Incorporated main Biocorporate entry.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.